Review



positive control article  (TargetMol)


Bioz Verified Symbol TargetMol is a verified supplier
Bioz Manufacturer Symbol TargetMol manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    TargetMol positive control article
    Positive Control Article, supplied by TargetMol, used in various techniques. Bioz Stars score: 97/100, based on 109 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/Bioactive+Compound+Library/us12661357-97-0-11
    Average 97 stars, based on 109 article reviews
    positive control article - by Bioz Stars, 2026-11
    97/100 stars

    Images

    Related Articles

    other:

    Article Title: P2Y12-oriented computational screening and functional validation identify antiplatelet compounds with antithrombotic activity.
    Article Snippet: Lysates were cleared at 12,000 × g for 10 min, and protein concentrations were determined using a BCA assay (Beyotime).

    Article Title: P2Y12-oriented computational screening and functional validation identify antiplatelet compounds with antithrombotic activity.
    Article Snippet: AutoDock Vina10 was used to dock the compound into the protein pocket and choose the best docking pose for the next analysis.

    Article Title: Discovery of 6l with a New Skeleton of 6-Oxo- N -(4-(Quinolin-4-yloxy)phenyl)-1,6-dihydropyridine-3-carboxamide as a Dual-Action Inhibitor against JNK2 and the MKK7-JNK2 Protein-Protein Interaction for Acute Lung Injury.
    Article Snippet: The development of anti-inflammatory drugs is a research focus.. Acute lung injury (ALI) is a life-threatening inflammatory syndrome that currently lacks effective pharmacotherapies.. Here, we report a potential therapy for ALI by targeting c-Jun N-terminal kinase 2 (JNK2), a key regulator of MAPK pathway-driven inflammatory responses.

    Article Title: From virtual screening to reality: Identifying potent PI3Kγ inhibitors for inflammation treatment by harnessing machine learning and biological validation.
    Article Snippet: Research increasingly shows that excessive activation of phosphoinositide 3-kinase gamma (PI3Kγ) is linked to numerous inflammatory factors, highlighting its potential as a drug target for inflammatory disorder treatment.. Nonetheless, few inhibitors have advanced to clinical trials for inflammation treatment.. One of the major reasons for this is the extreme difficulty in developing selective PI3Kγ inhibitors due to the high homology among kinase structures.

    Drug discovery:

    Article Title: Endoplasmic reticulum stress reduces caspofungin resistance in Cryptococcus neoformans .
    Article Snippet: .. Evaluation of additional ER inhibitors for potential synergy with caspofungin To further investigate the synergistic effects between caspofungin and endoplas mic reticulum (ER) stress pathways, we screened the TargetMol Endoplasmic Retic ulum (ER) Stress Compound Library (https://www.targetmol.com/compound-library/ Fig 4 (Continued) YNB, YNB with 10 μg/mL caspofungin, YNB with 125 ng/mL tunicamycin, YNB containing both caspofungin and tunicamycin for 48 h at 30°C. .. Cells were then resuspended in MM-250 mM KH2PO4 or MM-0 Pi medium, incubated at 30°C for 3 h. After incubation, supernatants (50 μL) of each sample were collected and used to measure acid phosphatase activity using the Acid Phosphatase Assay Kit from Sigma Aldrich (MAK446).

    Article Title: Mechanistic insights into phthalylsulfacetamide-induced restoration of meropenem bactericidal activity in NDM-1-positive Escherichia coli.
    Article Snippet: .. Small-molecule ligands were selected from the BioActive Compound Library (Target Mol, USA). ..

    Article Title: β1,4-galactosyltransferase III drives retinoblastoma invasion via activation of integrin-FAK axis
    Article Snippet: .. The TargetMol Bioactive Compound Library (T001; >18,000 natural products) was energy-minimized using LigPrep prior to screening. ..

    Article Title: β1,4-galactosyltransferase III drives retinoblastoma invasion via activation of integrin-FAK axis.
    Article Snippet: .. The TargetMol Bioactive Compound Library (T001; >18,000 natural products) was energy-minimised using LigPrep prior to screening. ..



    Similar Products

    99
    Illumina Inc illumina phix library
    Illumina Phix Library, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/PhiX+Control+v3/pmc13750924-62-1-1
    Average 99 stars, based on 1 article reviews
    illumina phix library - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Illumina Inc illumina phix control library
    Illumina Phix Control Library, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/PhiX+Control+v3/pmc13755692-134-13-13
    Average 99 stars, based on 1 article reviews
    illumina phix control library - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Illumina Inc thefinal libraries
    Thefinal Libraries, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/PhiX+Control+v3/10__1038_slash_s41467___026___78240___2-463-0-5
    Average 99 stars, based on 1 article reviews
    thefinal libraries - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Illumina Inc phix library
    Phix Library, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/PhiX+Control+v3/10__1007_slash_s40858___026___00851___3-111-16-18
    Average 99 stars, based on 1 article reviews
    phix library - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Illumina Inc phix control library
    Phix Control Library, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/PhiX+Control+v3/10__1186_slash_s13287___026___05192___1-190-42-45
    Average 99 stars, based on 1 article reviews
    phix control library - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    97
    TargetMol positive control article
    Positive Control Article, supplied by TargetMol, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/Bioactive+Compound+Library/us12661357-97-0-11
    Average 97 stars, based on 1 article reviews
    positive control article - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    97
    TargetMol positive control group
    Positive Control Group, supplied by TargetMol, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/Bioactive+Compound+Library/pm42237667-88-1-24
    Average 97 stars, based on 1 article reviews
    positive control group - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    94
    TargetMol compounds cell survival against dmso control
    High-throughput phenotypic assay screening of heterogeneous, patient-derived GBM cell lines. (A) High content phenotypic assay screening workflow on GBM cells. Five libraries were screened at multiple <t>concentrations</t> <t>(C3L,</t> 786 compounds at [0.003, 0.03, 0.3, 3] µm; KCGS, 187 compounds at [0.1, 1] µm; LOPAC, 1277 compounds at [0.5, 3] µm; Prestwick, 1276 compounds at [1, 10] µm; TargetMol-330, 330 compounds at [0.01, 0.1, 1, 10] µm). (B) Representative images of multiplex cell painting assay screen performed across the three main GBM cellular subtypes: classical (GCGR-E13, GCGR-E28), proneural (GCGR-E31, GCGR-E34), and mesenchymal (GCGR-E21, GCGR-E57). The cell painting stains shown are Hoechst (blue), phalloidin/WGA (green), and endoplasmic reticulum (red). (C) Density plots over all six GBM cell lines of the percentage of nuclei counts after compound treatment with respect to the average <t>DMSO</t> negative control (100%) per plate. After removal of duplicates, the dataset contains 3561 unique compounds. Colours correspond to each library (panel A), and only the highest concentration per library is shown. Cell line sensitivity to the compounds is variable across the cell lines; the bimodality displayed by the TargetMol library reveals a larger fraction of compounds that affect cell viability as compared to the other four libraries. (D) Density plots of the TargetMol library screen at all concentrations of cell line GCGR-E57 (top) and of cell line GCGR-E21 (bottom). The black dotted line represents the average DMSO negative control nuclei count. As the concentration increases, a larger number of compounds affects cell viability.
    Compounds Cell Survival Against Dmso Control, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/Autophagy+Compound+Library/pmc13181845-63-3-32
    Average 94 stars, based on 1 article reviews
    compounds cell survival against dmso control - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    97
    TargetMol positive control entry inhibitor
    (a) Percent inhibition of <t>entry</t> into HEK 293T/T17 and (b) relative cell viability with 22f treatment against pseudotyped (PT) MLVs expressing NWA GPCs for JUNV, MACV, GTOV, or TCRV. Viral entry results represent the percent reduction in entry by 22f compared to the vehicle <t>control.</t> Cytotoxicity was determined in parallel by measuring the viability of treated cells using the CellTiter-Glo Luminescent Cell Viability Assay, with luminescence units normalized to the average vehicle control luminescence for each experiment. The 22f compound was well tolerated by cells, exhibiting a toxicity profile comparable to that of the ch128.1 <t>positive-control</t> antibody treatment. Data shown are the means ± SD from two separate experiments for each pseudotyped virus. **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.
    Positive Control Entry Inhibitor, supplied by TargetMol, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/Bioactive+Compound+Library/pmc13270517-195-24-21
    Average 97 stars, based on 1 article reviews
    positive control entry inhibitor - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    Image Search Results


    High-throughput phenotypic assay screening of heterogeneous, patient-derived GBM cell lines. (A) High content phenotypic assay screening workflow on GBM cells. Five libraries were screened at multiple concentrations (C3L, 786 compounds at [0.003, 0.03, 0.3, 3] µm; KCGS, 187 compounds at [0.1, 1] µm; LOPAC, 1277 compounds at [0.5, 3] µm; Prestwick, 1276 compounds at [1, 10] µm; TargetMol-330, 330 compounds at [0.01, 0.1, 1, 10] µm). (B) Representative images of multiplex cell painting assay screen performed across the three main GBM cellular subtypes: classical (GCGR-E13, GCGR-E28), proneural (GCGR-E31, GCGR-E34), and mesenchymal (GCGR-E21, GCGR-E57). The cell painting stains shown are Hoechst (blue), phalloidin/WGA (green), and endoplasmic reticulum (red). (C) Density plots over all six GBM cell lines of the percentage of nuclei counts after compound treatment with respect to the average DMSO negative control (100%) per plate. After removal of duplicates, the dataset contains 3561 unique compounds. Colours correspond to each library (panel A), and only the highest concentration per library is shown. Cell line sensitivity to the compounds is variable across the cell lines; the bimodality displayed by the TargetMol library reveals a larger fraction of compounds that affect cell viability as compared to the other four libraries. (D) Density plots of the TargetMol library screen at all concentrations of cell line GCGR-E57 (top) and of cell line GCGR-E21 (bottom). The black dotted line represents the average DMSO negative control nuclei count. As the concentration increases, a larger number of compounds affects cell viability.

    Journal: Digital Discovery

    Article Title: Identification of drug candidates against glioblastoma with machine learning and high-throughput screening of heterogeneous cellular models

    doi: 10.1039/d5dd00190k

    Figure Lengend Snippet: High-throughput phenotypic assay screening of heterogeneous, patient-derived GBM cell lines. (A) High content phenotypic assay screening workflow on GBM cells. Five libraries were screened at multiple concentrations (C3L, 786 compounds at [0.003, 0.03, 0.3, 3] µm; KCGS, 187 compounds at [0.1, 1] µm; LOPAC, 1277 compounds at [0.5, 3] µm; Prestwick, 1276 compounds at [1, 10] µm; TargetMol-330, 330 compounds at [0.01, 0.1, 1, 10] µm). (B) Representative images of multiplex cell painting assay screen performed across the three main GBM cellular subtypes: classical (GCGR-E13, GCGR-E28), proneural (GCGR-E31, GCGR-E34), and mesenchymal (GCGR-E21, GCGR-E57). The cell painting stains shown are Hoechst (blue), phalloidin/WGA (green), and endoplasmic reticulum (red). (C) Density plots over all six GBM cell lines of the percentage of nuclei counts after compound treatment with respect to the average DMSO negative control (100%) per plate. After removal of duplicates, the dataset contains 3561 unique compounds. Colours correspond to each library (panel A), and only the highest concentration per library is shown. Cell line sensitivity to the compounds is variable across the cell lines; the bimodality displayed by the TargetMol library reveals a larger fraction of compounds that affect cell viability as compared to the other four libraries. (D) Density plots of the TargetMol library screen at all concentrations of cell line GCGR-E57 (top) and of cell line GCGR-E21 (bottom). The black dotted line represents the average DMSO negative control nuclei count. As the concentration increases, a larger number of compounds affects cell viability.

    Article Snippet: The density of compounds' cell survival against DMSO control at the maximum concentration per library (C3L – 3 μM, KCGS – 1 μM, LOPAC – 3 μM, Prestwick – 10 μM, and TargetMol – 10 μM) shows a bimodal distribution for the TargetMol library, with more treatments that affect the cells' viability.

    Techniques: Sample Throughput, Phenotypic Assay, Screening, Derivative Assay, Multiplex Assay, Cell Painting, Negative Control, Concentration Assay, Sensitivity, Fluorescence Microscopy

    (a) Percent inhibition of entry into HEK 293T/T17 and (b) relative cell viability with 22f treatment against pseudotyped (PT) MLVs expressing NWA GPCs for JUNV, MACV, GTOV, or TCRV. Viral entry results represent the percent reduction in entry by 22f compared to the vehicle control. Cytotoxicity was determined in parallel by measuring the viability of treated cells using the CellTiter-Glo Luminescent Cell Viability Assay, with luminescence units normalized to the average vehicle control luminescence for each experiment. The 22f compound was well tolerated by cells, exhibiting a toxicity profile comparable to that of the ch128.1 positive-control antibody treatment. Data shown are the means ± SD from two separate experiments for each pseudotyped virus. **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.

    Journal: ACS Infectious Diseases

    Article Title: Computer-Aided Discovery of Small-Molecule Inhibitors of Pathogenic New World Arenavirus Entry and Replication

    doi: 10.1021/acsinfecdis.6c00138

    Figure Lengend Snippet: (a) Percent inhibition of entry into HEK 293T/T17 and (b) relative cell viability with 22f treatment against pseudotyped (PT) MLVs expressing NWA GPCs for JUNV, MACV, GTOV, or TCRV. Viral entry results represent the percent reduction in entry by 22f compared to the vehicle control. Cytotoxicity was determined in parallel by measuring the viability of treated cells using the CellTiter-Glo Luminescent Cell Viability Assay, with luminescence units normalized to the average vehicle control luminescence for each experiment. The 22f compound was well tolerated by cells, exhibiting a toxicity profile comparable to that of the ch128.1 positive-control antibody treatment. Data shown are the means ± SD from two separate experiments for each pseudotyped virus. **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.

    Article Snippet: Follow-up pseudotyped LASV 22f viral entry inhibition assays and parallel cell viability assays were performed similarly, with the addition of LHF-535 (TargetMol) as a positive control entry inhibitor for OW arenavirus entry, which was prepared in the same vehicle control solution.

    Techniques: Inhibition, Expressing, Control, Cell Viability Assay, Positive Control, Virus